Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypertension
  Free Subscription

Articles published in
JAMA
    July 2026
  1. JURASCHEK SP, Kovell LC, Plante TB
    Review of Diagnosis and Management of Resistant Hypertension.
    JAMA. 2026 Jul 20. doi: 10.1001/jama.2026.9409.
    >> Share

  2. CORRAO S
    Review of Diagnosis and Management of Resistant Hypertension.
    JAMA. 2026 Jul 20. doi: 10.1001/jama.2026.9403.
    >> Share

  3. FENG A, Chen G, Li D
    Review of Diagnosis and Management of Resistant Hypertension.
    JAMA. 2026 Jul 20. doi: 10.1001/jama.2026.9406.
    >> Share

  4. AZIZI M, Kirtane AK
    Review of Diagnosis and Management of Resistant Hypertension-Reply.
    JAMA. 2026 Jul 20. doi: 10.1001/jama.2026.9412.
    >> Share

  5. ANDERER S
    Sugary Drink Consumption May Raise Hypertension Risk, Starting in Childhood.
    JAMA. 2026 Jul 10. doi: 10.1001/jama.2026.9475.
    >> Share

    June 2026
  6. WANG N, Van Der Hoorn S, Pant R, Kumar A, et al
    Adverse Effects and Treatment Discontinuation of Blood Pressure-Lowering Drugs and Combinations: A Network Meta-Analysis.
    JAMA. 2026;335:2135-2145.
    >> Share

  7. ANDERER S
    Some Common Food Additives Linked to Hypertension and CVD.
    JAMA. 2026 Jun 12. doi: 10.1001/jama.2026.8297.
    >> Share

  8. ANDERER S
    Single-Pill Combination Therapy for Hypertension Remains Underused.
    JAMA. 2026 Jun 5. doi: 10.1001/jama.2026.6204.
    >> Share

  9. HARDY ST, Emanuel E, Muntner P
    Blood Pressure Above Goal Among Adults With Hypertension in the US-Reply.
    JAMA. 2026 Jun 1. doi: 10.1001/jama.2026.5313.
    >> Share

  10. CASEY DE JR, Persell SD, Wozniak G
    Blood Pressure Above Goal Among Adults With Hypertension in the US.
    JAMA. 2026 Jun 1. doi: 10.1001/jama.2026.5310.
    >> Share

    May 2026
  11. MCDERMOTT MM, Persell SD
    Minimizing Adverse Effects in Hypertension Treatment.
    JAMA. 2026 May 28. doi: 10.1001/jama.2026.7685.
    >> Share

  12. BARONE GIBBS B, Kim J, Gallagher J, Jones MA, et al
    Adverse Pregnancy Outcomes and Sedentary Behavior, Light-Intensity Physical Activity, and Daily Steps.
    JAMA. 2026 May 27:e266986. doi: 10.1001/jama.2026.6986.
    >> Share

    April 2026
  13. ANDERER S
    Hypertension Burden Increasing Worldwide, With Stark Disparities.
    JAMA. 2026 Apr 17. doi: 10.1001/jama.2026.2114.
    >> Share

  14. ANDERER S
    Healthy Lifestyle Lowers Cardiometabolic Risk in People With Hypertension.
    JAMA. 2026 Apr 10. doi: 10.1001/jama.2026.2110.
    >> Share

    March 2026
  15. AZIZI M, Vongpatanasin W, Fisher NDL, Mahfoud F, et al
    Diagnosis and Management of Resistant Hypertension: A Review.
    JAMA. 2026 Mar 23. doi: 10.1001/jama.2026.1221.
    >> Share

  16. JOHNSON AE, Jackson CD, Alexander JT
    Management of Hypertension in Adults.
    JAMA. 2026 Mar 23. doi: 10.1001/jama.2026.1132.
    >> Share

    February 2026
  17. COHEN JB, Addo DK, Jacobs JA, Greene TH, et al
    Impact of a Smartwatch Hypertension Notification Feature for Population Screening.
    JAMA. 2026 Feb 9. doi: 10.1001/jama.2025.26925.
    >> Share

  18. HARDY ST, Jaeger BC, Emanuel E, Muntner P, et al
    Blood Pressure Above Goal Among US Adults With Hypertension.
    JAMA. 2026 Feb 2:e2525657. doi: 10.1001/jama.2025.25657.
    >> Share

    January 2026
  19. ANDERER S
    Combination Pills May Improve Hypertension.
    JAMA. 2026 Jan 23. doi: 10.1001/jama.2025.23034.
    >> Share

  20. JURASCHEK SP, Col H, Ferro K, Turkson-Ocran RN, et al
    DASH-Patterned Groceries and Effects on Blood Pressure: The GoFresh Randomized Clinical Trial.
    JAMA. 2026;335:36-48.
    >> Share

    December 2025
  21. PANT S
    Chronic Pain Linked to Hypertension.
    JAMA. 2025 Dec 12. doi: 10.1001/jama.2025.20022.
    >> Share

  22. ANDERER S
    Hypertension Among Children Has Increased Significantly.
    JAMA. 2025 Dec 5. doi: 10.1001/jama.2025.20012.
    >> Share

    November 2025
  23. MAYA J, Pant D, Fu Y, James K, et al
    Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation.
    JAMA. 2025 Nov 24:e2520951. doi: 10.1001/jama.2025.20951.
    >> Share

    October 2025
  24. TAI YH, Fu TC, Chang CM
    Lorundrostat for Uncontrolled Hypertension and Treatment-Resistant Hypertension.
    JAMA. 2025 Oct 22. doi: 10.1001/jama.2025.16167.
    >> Share

  25. SAXENA M, Rodman D
    Lorundrostat for Uncontrolled Hypertension and Treatment-Resistant Hypertension-Reply.
    JAMA. 2025 Oct 22. doi: 10.1001/jama.2025.16170.
    >> Share

    September 2025
  26. DESAI A, Havasi A, Saxena M
    Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension-Reply.
    JAMA. 2025 Sep 24. doi: 10.1001/jama.2025.13329.
    >> Share

  27. CHEN T, Zhu Z
    Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension.
    JAMA. 2025 Sep 24. doi: 10.1001/jama.2025.13326.
    >> Share

  28. ZHU J, Zhang W
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12790.
    >> Share

  29. GAO M, Cao T, Wu Q
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12787.
    >> Share

  30. GARRISON SR, Kolber MR, Korownyk CS
    Timing of Antihypertensive Medications and Cardiovascular Outcomes-Reply.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12796.
    >> Share

  31. CEDERNAES J, Benedict C
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12784.
    >> Share

  32. FENG S, Li H, Sun R
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12793.
    >> Share

  33. XU Q, Gao Y, Zhang O
    Medications for Resistant Hypertension.
    JAMA. 2025 Sep 15. doi: 10.1001/jama.2025.12653.
    >> Share

  34. BROOK RD, Cohen JB, Rajagopalan S
    Medications for Resistant Hypertension-Reply.
    JAMA. 2025 Sep 15. doi: 10.1001/jama.2025.12656.
    >> Share

  35. GAO M, Cao T, Wu Q
    Hypertension Medications and Health-Related Quality of Life.
    JAMA. 2025 Sep 10. doi: 10.1001/jama.2025.12228.
    >> Share

  36. LEE CJ, Kim DH, Park S
    Hypertension Medications and Health-Related Quality of Life-Reply.
    JAMA. 2025 Sep 10. doi: 10.1001/jama.2025.12231.
    >> Share

    August 2025
  37. ANDERER S, Rekito A
    Hypertension Survey Finds Many US Adults Lack Key Knowledge of the Condition.
    JAMA. 2025 Aug 15. doi: 10.1001/jama.2025.13589.
    >> Share

  38. SCHNEIDER L
    Medication Timing Could Influence Hypertension Treatment.
    JAMA. 2025 Aug 1. doi: 10.1001/jama.2025.10983.
    >> Share

    June 2025
  39. SAXENA M, Laffin L, Borghi C, Fernandez Fernandez B, et al
    Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical Trial.
    JAMA. 2025 Jun 30:e259413. doi: 10.1001/jama.2025.9413.
    >> Share

  40. ANDERER S
    Study Shows Decline in Hypertension Awareness Among US Adults.
    JAMA. 2025 Jun 27. doi: 10.1001/jama.2025.9633.
    >> Share

    May 2025
  41. DESAI AS, Karns AD, Badariene J, Aswad A, et al
    Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial.
    JAMA. 2025 May 28:e256681. doi: 10.1001/jama.2025.6681.
    >> Share

  42. CHEBIB FT, Hanna C, Harris PC, Torres VE, et al
    Autosomal Dominant Polycystic Kidney Disease: A Review.
    JAMA. 2025;333:1708-1719.
    >> Share

  43. LEE CJ, Ihm SH, Shin DH, Jeong JO, et al
    Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical Trial.
    JAMA. 2025 May 14:e255129. doi: 10.1001/jama.2025.5129.
    >> Share

  44. BROOK RD, Cohen JB, Rajagopalan S
    New Support for Old Medications in Resistant Hypertension.
    JAMA. 2025 May 14. doi: 10.1001/jama.2025.4321.
    >> Share

  45. TALER SJ
    Morning or Nighttime Medication Dosing-Does It Matter in the Treatment of Hypertension?
    JAMA. 2025 May 12. doi: 10.1001/jama.2025.7286.
    >> Share

  46. GARRISON SR, Bakal JA, Kolber MR, Korownyk CS, et al
    Antihypertensive Medication Timing and Cardiovascular Events and Death: The BedMed Randomized Clinical Trial.
    JAMA. 2025 May 12:e254390. doi: 10.1001/jama.2025.4390.
    >> Share

    February 2025
  47. ANDERER S
    Supine Hypertension Linked to Cardiovascular Risk Regardless of Seated Blood Pressure.
    JAMA. 2025 Feb 21. doi: 10.1001/jama.2025.0544.
    >> Share

    January 2025
  48. ANDERER S
    Hypertensive Disorders of Pregnancy May Be Associated With Future Neurological Issues.
    JAMA. 2025 Jan 24. doi: 10.1001/jama.2024.28057.
    >> Share

    November 2024
  49. GARG AX, Cuerden MS, Sontrop JM
    Hypertension Risk and Kidney Function Following Kidney Donation-Reply.
    JAMA. 2024 Nov 20. doi: 10.1001/jama.2024.21430.
    >> Share

  50. LIN Y, Huang J
    Hypertension Risk and Kidney Function Following Kidney Donation.
    JAMA. 2024 Nov 20. doi: 10.1001/jama.2024.21427.
    >> Share

  51. ZHONG P, Liu X, Liao L
    Hypertension Risk and Kidney Function Following Kidney Donation.
    JAMA. 2024 Nov 20. doi: 10.1001/jama.2024.21424.
    >> Share

    October 2024
  52. ANDERER S
    More Than Half of US Adults With Uncontrolled Hypertension Don't Know They Have It.
    JAMA. 2024 Oct 11. doi: 10.1001/jama.2024.20117.
    >> Share

  53. ABBASI J
    Semaglutide Updates, Hypertension Triple Pills, and More-Heart Health Highlights From ESC Congress.
    JAMA. 2024 Oct 4. doi: 10.1001/jama.2024.19544.
    >> Share

    August 2024
  54. OJJI DB, Salam A, Sani MU, Ogah OS, et al
    Low-Dose Triple-Pill vs Standard-Care Protocols for Hypertension Treatment in Nigeria: A Randomized Clinical Trial.
    JAMA. 2024 Aug 31. doi: 10.1001/jama.2024.18080.
    >> Share

  55. MENSAH GA
    Is a Low-Dose Triple-Drug Combination Pill Protocol the Answer for Hypertension Control in Sub-Saharan Africa?
    JAMA. 2024 Aug 31. doi: 10.1001/jama.2024.18166.
    >> Share

    July 2024
  56. DIAO JA, Shi I, Murthy VL, Buckley TA, et al
    Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations.
    JAMA. 2024 Jul 29:e2412537. doi: 10.1001/jama.2024.12537.
    >> Share

  57. HARRIS E
    Self-Monitoring and Managing Medications Improved High Blood Pressure.
    JAMA. 2024;332:7-8.
    >> Share

    June 2024
  58. BOCK A
    Antihypertensives Might Explain Some Older Adults' New Eczema Diagnoses.
    JAMA. 2024 Jun 21. doi: 10.1001/jama.2024.10347.
    >> Share

  59. HARRIS E
    Blood Pressure Drugs Linked to More Fractures, Falls in VA Nursing Homes.
    JAMA. 2024;331:1982.
    >> Share

  60. OGEDEGBE G, Teresi JA, Williams SK, Ogunlade A, et al
    Home Blood Pressure Telemonitoring and Nurse Case Management in Black and Hispanic Patients With Stroke: A Randomized Clinical Trial.
    JAMA. 2024 Jun 6. doi: 10.1001/jama.2024.6609.
    >> Share

    May 2024
  61. HARRIS E
    Swapping Salt for a Substitute May Lower Deaths, Reduce Heart Problems.
    JAMA. 2024;331:1698-1699.
    >> Share

  62. GARG AX, Arnold JB, Cuerden MS, Dipchand C, et al
    Hypertension and Kidney Function After Living Kidney Donation.
    JAMA. 2024 May 23. doi: 10.1001/jama.2024.8523.
    >> Share

    April 2024
  63. LI W
    Blood Pressure Self-Management After Hypertensive Pregnancy.
    JAMA. 2024;331:1156.
    >> Share

  64. KITT J, McManus RJ, Leeson P
    Blood Pressure Self-Management After Hypertensive Pregnancy-Reply.
    JAMA. 2024;331:1156-1157.
    >> Share

    March 2024
  65. HARRIS E
    Tirzepatide Lowered Blood Pressure in People With Obesity.
    JAMA. 2024;331:821.
    >> Share

  66. HARRIS E
    Weight Loss Surgery Managed Blood Pressure for People With Obesity.
    JAMA. 2024;331:725-726.
    >> Share

    February 2024
  67. ESTRADA RA, Auger WR, Sahay S
    Chronic Thromboembolic Pulmonary Hypertension.
    JAMA. 2024 Feb 26. doi: 10.1001/jama.2023.24265.
    >> Share

  68. SCHIFFRIN EL
    RNA Injection Every 6 Months to Improve Adherence and Lower Blood Pressure in Patients With Hypertension.
    JAMA. 2024 Feb 16. doi: 10.1001/jama.2023.26071.
    >> Share

  69. BAKRIS GL, Saxena M, Gupta A, Chalhoub F, et al
    RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial.
    JAMA. 2024 Feb 16. doi: 10.1001/jama.2024.0728.
    >> Share

  70. PALMA JA, Kaufmann H
    Pharmacologic Treatment for High BP and Risk of CVD.
    JAMA. 2024;331:530-531.
    >> Share

  71. JURASCHEK SP, Mukamal KJ
    Pharmacologic Treatment for High BP and Risk of CVD-Reply.
    JAMA. 2024;331:531-532.
    >> Share

    November 2023
  72. ELMALEH-SACHS A, Schwartz JL, Bramante CT, Nicklas JM, et al
    Obesity Management in Adults: A Review.
    JAMA. 2023;330:2000-2015.
    >> Share

  73. HARRIS E
    Remote Hypertension Monitoring Improved Medication Use, Raised Costs.
    JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22936.
    >> Share

  74. KITT J, Fox R, Frost A, Shanyinde M, et al
    Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management: The POP-HT Randomized Clinical Trial.
    JAMA. 2023 Nov 11. doi: 10.1001/jama.2023.21523.
    >> Share

  75. GUPTA DK, Lewis CE, Varady KA, Su YR, et al
    Effect of Dietary Sodium on Blood Pressure: A Crossover Trial.
    JAMA. 2023 Nov 11. doi: 10.1001/jama.2023.23651.
    >> Share

    October 2023
  76. BYRD JB, Bisognano JD, Brook RD
    Treating Hypertension in Patients With Orthostatic Hypotension: Benefits vs Harms in the Era of Aggressive Blood Pressure Lowering.
    JAMA. 2023;330:1435-1436.
    >> Share

  77. JURASCHEK SP, Hu JR, Cluett JL, Ishak AM, et al
    Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis.
    JAMA. 2023;330:1459-1471.
    >> Share

  78. HARRIS E
    Majority of People Live With Uncontrolled Hypertension Worldwide.
    JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19204.
    >> Share

  79. SANCHEZ-DE-LA-TORRE M, Gracia-Lavedan E, Benitez ID, Sanchez-de-la-Torre A, et al
    Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis.
    JAMA. 2023;330:1255-1265.
    >> Share

    September 2023
  80. DENOBLE AE, Pettker CM
    Hypertension Screening in Pregnancy: Remembering the Basics, Charting the Future.
    JAMA. 2023;330:1040-1041.
    >> Share

  81. HENDERSON JT, Webber EM, Thomas RG, Vesco KK, et al
    Screening for Hypertensive Disorders of Pregnancy: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2023;330:1083-1091.
    >> Share

  82. BARRY MJ, Nicholson WK, Silverstein M, Cabana MD, et al
    Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement.
    JAMA. 2023;330:1074-1082.
    >> Share

  83. JIN J
    Screening for High Blood Pressure Disorders During Pregnancy.
    JAMA. 2023;330:1107.
    >> Share

  84. WILLIAMS B
    A New Dawn for Aldosterone as a Therapeutic Target in Hypertension.
    JAMA. 2023 Sep 10. doi: 10.1001/jama.2023.17087.
    >> Share

  85. LAFFIN LJ, Rodman D, Luther JM, Vaidya A, et al
    Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial.
    JAMA. 2023 Sep 10:e2316029. doi: 10.1001/jama.2023.16029.
    >> Share

  86. HARRIS E
    High Blood Pressure More Likely After COVID-19 Than Flu.
    JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16676.
    >> Share

  87. MISTRY EA, Hart KW, Davis LT, Gao Y, et al
    Blood Pressure Management After Endovascular Therapy for Acute Ischemic Stroke: The BEST-II Randomized Clinical Trial.
    JAMA. 2023;330:821-831.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016